1.78
Tiziana Life Sciences Ltd (TLSA) 最新ニュース
What analysts say about Tiziana Life Sciences Ltd stockOutstanding stock performance - Autocar Professional
Tiziana Life Sciences Ltd Stock Analysis and ForecastOutstanding risk-reward balance - Autocar Professional
What drives Tiziana Life Sciences Ltd stock priceExponential wealth increase - jammulinksnews.com
Is Tiziana Life Sciences Ltd a good long term investmentAccelerated wealth expansion - jammulinksnews.com
Promising Penny Stocks To Watch In July 2025 - Yahoo Finance
Tiziana Life Sciences stock initiated with Buy rating at Lucid Capital Markets - Investing.com Australia
Tiziana Life Sciences (TLSA) Receives Buy Rating with Promising Outlook | TLSA Stock News - GuruFocus
Tiziana Life Sciences reports encouraging results from nasal Alzheimer’s treatment - Proactive financial news
Breakthrough: New Alzheimer's Drug Shows Unexpected Dual ActionFights Inflammation and Amyloid Plaques - Stock Titan
Will Tiziana Life Sciences Ltd stock benefit from interest rate changesFree Predictions - beatles.ru
Is Tiziana Life Sciences Ltd stock a growth or value playFree Financial Group - Newser
What analysts say about Tiziana Life Sciences Ltd stock outlookFree Risk Assessment Services - Newser
Why Tiziana Life Sciences Ltd stock is on top investor watchlistsFree Access to Investment Community - Newser
How Tiziana Life Sciences Ltd stock performs during market volatilityROI Driven Alerts - Newser
What makes Tiziana Life Sciences Ltd stock price move sharplySteady Profit Stock Forecasts - Newser
Why Tiziana Life Sciences Ltd stock attracts strong analyst attentionFree Access to Investors Club - Newser
Multiple Sclerosis Pipeline Landscape Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Promising Penny Stocks To Consider In June 2025 - simplywall.st
Tiziana: Scope Of Foralumab Goes Beyond That Of Multiple Sclerosis Targeting (NASDAQ:TLSA) - Seeking Alpha
Tiziana Life Sciences Adds Fifth Site for Phase 2 Foralumab Trial in Multiple Sclerosis - MarketScreener
Small cap wrap: Tiziana Life Sciences, Challenger Energy, Arrow Exploration... - Proactive financial news
Tiziana expands Phase 2 MS trial to fifth site, commences patient dosing - Proactive financial news
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center - The Manila Times
Breakthrough Multiple Sclerosis Treatment Enters Next Phase as Weill Cornell Joins Major Clinical Trial - Stock Titan
Market movers: RH, Tiziana, Archer Aviation... - Proactive Investors
Shares of Tiziana Life Sciences (TLSA) Climb on CEO's Upcoming P - GuruFocus
Tiziana shares rise on presentation date for foralumab data - Seeking Alpha
Tiziana CEO to present clinical advances of intranasal foralumab at BIO 2025 - Proactive financial news
Tiziana Life Sciences to Present at the Bio International Convention - The Manila Times
大文字化:
|
ボリューム (24 時間):